Sales decline 27.17% to Rs 410.30 crore
Net profit of Natco Pharma declined 38.93% to Rs 75.00 crore in the quarter ended June 2021 as against Rs 122.80 crore during the previous quarter ended June 2020. Sales declined 27.17% to Rs 410.30 crore in the quarter ended June 2021 as against Rs 563.40 crore during the previous quarter ended June 2020. ParticularsQuarter EndedJun. 2021Jun. 2020% Var.Sales410.30563.40 -27 OPM %26.7630.37 -PBDT124.80186.10 -33 PBT91.00158.10 -42 NP75.00122.80 -39Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content